Alignment Healthcare, Inc.
HealthcareNASDAQ:ALHC · NASDAQ Global Select
-$0.49 today
Vol 4.31M · Avg 5.26M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $1.4B |
| Receivables | $277.7M |
| Other Current | -$543.5M |
| Total Current Assets | $1.1B |
| PP&E (Net) | $70.9M |
| Goodwill | $32.1M |
| Intangible Assets | $4.5M |
| Long-term Investments | $20.7M |
| Other Non-current | -$12.0M |
| Total Non-current Assets | $116.2M |
| Total Assets | $1.3B |
Analysis
Selected assets total $1.3B for Latest. The largest visible component is Cash & Equivalents at $1.4B, about 111.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $577.9M +33.5% | $432.9M +113.3% | $202.9M -50.5% | $409.5M -12.2% | $466.6M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 -100.0% | $37.8M -67.4% | $115.9M | $0 | $0 | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $253.2M +64.5% | $153.9M +28.5% | $119.7M +28.9% | $92.9M +58.8% | $58.5M | $533.8M | $399.4M | -$1.7B |
| Inventory | $0 | $0 | $0 | $0 | $0 | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $0 -100.0% | $37.1M -17.5% | $45.0M +6.8% | $42.1M | $0 | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $831.1M +25.6% | $661.6M +36.8% | $483.5M -11.2% | $544.5M -1.5% | $552.9M | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $71.3M -4.9% | $75.0M +21.2% | $61.9M +43.9% | $43.0M +12.5% | $38.2M | $1.2B | $1.5B | $687.8M |
| Goodwill | $32.1M -7.9% | $34.8M +0.0% | $34.8M +0.0% | $34.8M +18.8% | $29.3M | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $4.5M +0.0% | $4.5M -13.4% | $5.3M -4.1% | $5.5M -5.8% | $5.8M | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $28.4M | $0 | $0 | $0 | $0 | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 | $0 | $0 | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $98.3M +1514.4% | $6.1M -4.9% | $6.4M +6.1% | $6.0M +28.2% | $4.7M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $234.6M +94.8% | $120.4M +11.2% | $108.3M +21.3% | $89.3M +14.5% | $78.0M | -$15.3B | $14.8B | $11.3B |
| Total Assets | $1.1B +36.3% | $782.1M +32.1% | $591.9M -6.6% | $633.9M +0.5% | $630.9M | $13.3B | $11.9B | $10.6B |
| Account Payables | $474.6M +95.7% | $242.5M +42.6% | $170.1M -1.1% | $171.9M +886.3% | $17.4M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $2.0M +61.6% | $1.2M | $0 | $0 | $0 | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 | $0 | $0 | $0 | $0 | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $0 -100.0% | $38.7M +13.5% | $34.1M | $0 | $0 | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $476.5M +35.4% | $351.8M +33.8% | $263.0M +14.4% | $230.0M +37.5% | $167.2M | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $323.2M +0.5% | $321.4M +98.6% | $161.8M +0.6% | $160.9M +6.8% | $150.6M | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $73.9M | $0 | $0 | $0 | $0 | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $410.0M +24.5% | $329.3M +92.8% | $170.8M +3.8% | $164.6M +4.4% | $157.6M | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $886.5M +30.2% | $681.1M +57.0% | $433.8M +9.9% | $394.6M +21.5% | $324.8M | $14.7B | $3.7B | $9.6B |
| Common Stock | $205.0K +6.8% | $192.0K +1.6% | $189.0K +1.1% | $187.0K +0.0% | $187.0K | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$1.0B -0.1% | -$1.0B -14.5% | -$880.3M -20.2% | -$732.2M -25.7% | -$582.7M | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $0 | $0 | $0 | $0 | $0 | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 -100.0% | $1.1M -1.9% | $1.1M -4.3% | $1.2M +7740.0% | $15.0K | $1.4B | $337.8M | $931.4M |
| Total Equity | $179.3M +77.6% | $101.0M -36.1% | $158.1M -33.9% | $239.3M -21.8% | $306.1M | $9.1B | $7.7B | $3.3B |
| Total Debt | $338.1M +2.7% | $329.3M +92.8% | $170.8M +3.8% | $164.6M +4.4% | $157.6M | $724.2M | $410.6M | $399.4M |
| Net Debt | -$239.9M -131.5% | -$103.6M -222.6% | -$32.1M +86.9% | -$244.9M +20.7% | -$309.0M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Oscar Health, Inc.
NYSE:OSCR
$7.33B
Apogee Therapeutics, Inc.
NASDAQ:APGE
$5.47B
Mirum Pharmaceuticals, Inc.
NASDAQ:MIRM
$4.99B
Envista Holdings Corp
NYSE:NVST
$4.00B
ICU Medical, Inc.
NASDAQ:ICUI
$3.55B
Dyne Therapeutics, Inc.
NASDAQ:DYN
$3.01B
Privia Health Group, Inc.
NASDAQ:PRVA
$2.95B
Soleno Therapeutics, Inc.
SLNO
$2.76B
GRAIL, Inc.
NASDAQ:GRAL
$2.57B
Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE
$2.40B
SEC Filings
Recent regulatory filings
No filings found.
How much cash does ALHC have?
Alignment Healthcare, Inc. (ALHC) reported $577.94M in cash and equivalents in fiscal 2025.
How much debt does ALHC carry?
Alignment Healthcare, Inc. (ALHC) reported $338.07M of total debt, with net debt of -$239,869,000.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.